 |
|
|
| |
Relative Bioavailability of Darunavir/Cobicistat/Emtricitabine/
Tenofovir Alafenamide (D/C/F/TAF) Single-Tablet Regimen
When Administered as a Whole, Split, or Crushed Tablet
|
| |
| |
Reported by Jules Levin
16th European AIDS Conference, October 25-27, 2017. Milan
Kimberley Brown,1 David Thomas,2 Kevin McKenney,2 Michael Reeder,3 Richard B. Simonson,1 Ceyhun Bicer,4 Richard E. Nettles,1 Herta Crauwels5
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA
2Janssen Research & Development, LLC, Titusville, NJ, USA
3Janssen Research & Development, LLC, Raritan, NJ, USA
4BICER Consulting & Research, Antwerp, Belgium
5Janssen Research & Development, Beerse, Belgium
|
| |
|
|
|
|
|
